Alternative therapies for advanced prostate cancer. What should I tell my patients? (Q77851800)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10361563%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Alternative therapies for advanced prostate cancer. What should I tell my patients? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10361563%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

M A Moyad

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10361563%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 May 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10361563%20AND%20SRC:MED&resulttype=core&format=json

Urologic Clinics of North America

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10361563%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10361563%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10361563%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

413-7, x

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10361563%20AND%20SRC:MED&resulttype=core&format=json

A pilot study of metoclopramide, dexamethasone, diphenhydramine and acupuncture in women treated with cisplatin.

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970080-X

7 January 2021

Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970080-X

7 January 2021

St John's wort as an antidepressant

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970080-X

7 January 2021

Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970080-X

7 January 2021

Prolongation of the antiemetic action of P6 acupuncture by acupressure in patients having cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970080-X

7 January 2021

Non-invasive stimulation of the P6 (Neiguan) antiemetic acupuncture point in cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970080-X

7 January 2021

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970080-X

7 January 2021

Acupuncture for the relief of cancer-related breathlessness

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970080-X

7 January 2021

Effectiveness and tolerance of the hypericum extract LI 160 compared to maprotiline: a multicenter double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970080-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970080-X

7 January 2021

Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970080-X

7 January 2021

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970080-X

7 January 2021

Prevalence and cost of alternative medicine in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970080-X

7 January 2021

Use of PC-SPES, a commercially available supplement for prostate cancer, in a patient with hormone-naive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970080-X

7 January 2021

Biologically active and other chemical constituents of the herb of Hypericum perforatum L.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970080-X

7 January 2021

Adverse effects of acupuncture

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970080-X

7 January 2021

Current trends in the integration and reimbursement of complementary and alternative medicine by managed care, insurance carriers, and hospital providers

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970080-X

7 January 2021

Management of cancer pain in Denmark: a nationwide questionnaire survey

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970080-X

7 January 2021

Controlled clinical trials of hypericum extracts in depressed patients--an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970080-X

7 January 2021

Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970080-X

7 January 2021

Courses involving complementary and alternative medicine at US medical schools.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970080-X

7 January 2021

Benefits and risks of the hypericum extract LI 160: drug monitoring study with 3250 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970080-X

7 January 2021

Herbal remedies in psychiatric practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970080-X

7 January 2021

Adverse events related to acupuncture

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970080-X

7 January 2021

10.1016/S0094-0143(05)70080-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10361563%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference